key: cord-0953849-t84jq5wy
authors: Ashoor, Dana; Marzouq, Maryam; Trabelsi, Khaled; Chlif, Sadok; Abotalib, Nasser; Ben Khalaf, Noureddine; Ramadan, Ahmed R.; Fathallah, M-Dahmani
title: HOW CONCERNING IS A SARS-COV-2 VARIANT OF CONCERN? COMPUTATIONAL PREDICTIONS AND THE VARIANTS LABELING SYSTEM
date: 2022-02-02
journal: bioRxiv
DOI: 10.1101/2022.01.31.478425
sha: ec0e6296153d18d35125eb54f08c8ac883f9cbc0
doc_id: 953849
cord_uid: t84jq5wy

We herein report a study to evaluate the use of computational prediction of SARS-CoV-2 genetic variations in improving the current variants labeling system. First, we reviewed the basis of the system developed by the World Health Organization (WHO) for the labeling of SARS-CoV-2 genetic variants and the adaptations made to it by the United States Center of Diseases Control (CDC). We observed that the labeling system is based upon the virus’ major attributes. However, we found that the labeling criteria of the SARS-CoV-2 variants derived from these attributes are not accurately defined and are used differently by the two health management agencies. Consequently, discrepancies exist between the labels given by WHO and CDC to same variants. Our observations suggest that giving the VOC label to a new variant is premature and might not be appropriate. Therefore, we carried out a comparative computational study to predict the effects of the mutations on the virus structure and functions of five VOCs. By linking these data to the criteria used by WHO and the CDC for variant labeling, we ascertained that comparative computational predictions of the impact of genetic variations are a better ground for rapid and more accurate labelling of SARS-CoV-2 variants. We propose to label all emergent variants VUM or VBM and to carry out computational predictive studies and thorough variants comparison, upon which more appropriate and informative labels can be attributed. Furthermore, harmonization of the variants labeling system would be globally beneficial to communicate about and fight COVID-19 pandemic.

We herein report a study to evaluate the use of computational prediction of SARS-CoV-2 genetic 27

variations in improving the current variants labeling system. First, we reviewed the basis of the 28 system developed by the World Health Organization (WHO) for the labeling of SARS-CoV-2 29 genetic variants and the adaptations made to it by the United States Center of Diseases Control 30 (CDC). We observed that the labeling system is based upon the virus' major attributes. However, 31

we found that the labeling criteria of the SARS-CoV-2 variants derived from these attributes are 32

not accurately defined and are used differently by the two health management agencies. 33

Consequently, discrepancies exist between the labels given by WHO and CDC to same variants. 34

Our observations suggest that giving the VOC label to a new variant is premature and might not 35 be appropriate. Therefore, we carried out a comparative computational study to predict the effects 36 of the mutations on the virus structure and functions of five VOCs. By linking these data to the 37 criteria used by WHO and the CDC for variant labeling, we ascertained that comparative 38 computational predictions of the impact of genetic variations are a better ground for rapid and 39 more accurate labelling of SARS-CoV-2 variants. We propose to label all emergent variants VUM 40

or VBM and to carry out computational predictive studies and thorough variants comparison, upon 41

which more appropriate and informative labels can be attributed. Furthermore, harmonization of 42 the variants labeling system would be globally beneficial to communicate about and fight COVID-43 19 pandemic. World Health Organization (WHO) announced a labeling system to categorize the variants into 66 different levels of priority to better organize the global monitoring and research, and ultimately 67 organize the "infodemic" and communicate more effectively with the public about the adequate 68 response to the emergence of new variants of SARS-CoV-2 (https://www.who.int/ concern (VOC), variants of interest (VOI) and variant under monitoring (VUM). This labeling 78 system is based upon definitions related to variant phenotypic attributes such as transmissibility, 79 disease presentation, effect on current diagnostic tests and response to available vaccines. This 80 system was set to prompt and harmonize the actions needed to control the spread of a given variant. 81

While the variants that emerged sequentially were named and  the last emerging one was 82 named omicron which does not comply with the sequence of the Greek alphabetic order that call 83

for naming this variant "Nu". WHO deemed that "Nu" is prone to confusion with "New". Xi was 84

also not used because it is a common surname in Asia. Therefore, this variant was named 85

"Omicron". Of interest is that the American Center for disease control has also adopted this system 86 of variant classification and labelling but added more labels and labeling criteria and a different 87 labels' change policy (https://www.cdc.gov/). Indeed, while keeping the labels, variant of concern 88 (VOC), variant of interest (VOI) and variant under monitoring (VUM) (calling the later "VBM" 89

for Variant Being Monitored). In addition, the CDC uses an extra label that is the "Variant Of High 90

Consequences" (VOHC CDC to give a particular label to a new variant. These criteria are derived from six viral attributes 172 (Table 1) . To each attribute, correspond a set of criteria that are formulated differently by each 173

agency (see Table 1 ) who considers different criteria in their working definition of each label. 174 Figure 1 shows that the two agencies use common (VOC, VOI) and different (VUM, VBM and 175 VOHC) labels. Each agency uses generally different combination of criteria to give a variant a 176 specific label except in four instances shown in Figure 1 where they use overlapping criteria for 177 the same label (VOC and VOI). Consequently, there are discrepancies in the labels of currently 178 active variants. Indeed, while WHO is currently labeling variants  and omicron as VOC, 179

for the CDC, only variant omicron is labeled VOC. Indeed, the CDC declassified variants , 180

and to VBM. In addition, there are no variants currently labelled VOI by the CDC. Figure 1  181 illustrates the differential use by WHO and the CDC of the viral attributes-derived criteria to label 182 the SARS-CoV-2 genetic variants. 183 184 mutations occurred in the S spike protein and fifteen are clustered in the RBD region. The 227

representation of the mutations in the S protein 3D models of SARS-CoV-2 five VOCs shows that 228 most of the mutations map to the solvent exposed regions (Figure 3 and Supplementary Non-synonymous mutations of the different SARS-CoV-2 variants caused changes on the epitope 233 probability and antibody exposure hence immunogenicity. Most of the epitope changes are 234 noticeable in the S1 domain of the spike protein. Figure 4 shows the percentage of the exposed 235 epitope on the different variants. Computational methods allow the building of accurate protein models of the SARS-CoV-2 S 242 protein based on data input and the alignment with experimentally solved multiple templates 243 molecules. We used the Phyre2 web server to generate 3D models for the extracellular domain of 244 the variants and  monomers spike protein (Fig 5) . The structures were generated with 245 100% confidence and 84% coverage for alpha, beta and omicron, and 83% coverage for gamma 246

and delta by the single highest scoring template. The quality assessment of these models obtained 247

by superimposition with the crystalized structure of the SARS-CoV-2 spike glycoprotein (closed 248 state) 6VXX Chain B, showed an RMSD of 1.086 for alpha, 1.085 for beta, 1.079 for gamma, 249

1.075 for delta and 1.075 for omicron (Fig. 5) . The Tm-scores were all less than 1 and both RMSD 250

and TM-scoring values are acceptable and indicates high similarity between the crystalized model 251 and the generated one showing the same folds. In addition, CMView common contact map gave 252 a high similarity score ranging between 80% -81.5% keeping in mind that the crystalized structure 253

is missing few residues (gaps) including the furin cleavage loop. What is important here is that 254 these generated models include the furin cleavage site that is lacked in all the crystalized models 255 deposited on the protein database (PDB). Moreover, comparison of the contact map percentage 256

and TM-align scoring gave an indication of the similarity between the different models (Table 4) . 257

Given the highly reliable Tm score and RMSD values, the computationally generated models are 258 suitable to be used for further analysis especially for evaluating the effect of mutations on and 259

around the furin cleavage site. showed destabilizing effect that we reported previously (Ashoor et al., 2021) ( Using the crystalized structure PDB ID 6LZG that represent the interaction between SARS-CoV-286

2 receptor binding domain with ACE2 receptor as a reference, we generated models for the five 287

variants on the LigPlot+ software and analyzed the polar interaction patterns. The interacting 288

residues and type of interactions are listed in Table 6 . All the variants have one or more mutations 289 on the contact residues except for the delta variant. At a first glance to Table 6 transmissibility.

In addition to Glu484, other mutations on RBD binding hot spots residues, have been also linked 303

to antibody binding and neutralization including mutations on Lys417, Gly446, Phe456, Asn501, 304

Gly477 CDC has adopted this labeling system but introduced major changes. Among the labels used by 326

WHO and the CDC is the label "Variant Of Concern or VOC". The word "concern" is synonymous 327 of anguish, anxiety and apprehension. It naturally enjoins fear and disturbance, which predispose 328

to take immediate actions and make odd changes. Indeed, when a new variant is labeled VOC, 329

countries are inclined to close their borders and take drastic counter measures. This was 330

particularly striking when a number of countries banned travels from South Africa that was the 331 first country to describe and report the genomic sequence of the omicron variant. While preventive 332

and cautionary actions are mandatory to control pandemics, these should be based on solid 333 scientific evidences. However, it takes time and coordinated efforts for the scientific community 334

to generate the data needed to label accurately new variants according to criteria such as 335 transmissibility, disease severity, and change in the epidemiological pattern, immune escape, and 336 resistance to previously neutralizing antibodies, efficacy of existing therapies or vaccine 337 efficiency. Meanwhile, the rapid pandemic progress requires timely response including a good 338

communication system. In this study, we highlight some flaws in the labeling system developed 339

by WHO mainly to ease communication with the national health authorities and the public. Indeed, 340

in addition to the non-appropriate wording for labeling emergent variant, the combination of 341 criteria used to define a variant label as shown in WHO and the CDC web sites, is not accurate. 342

Indeed, in their definitions of the different labels, both agencies build a combination of criteria 343 using the prefix "OR" but not "AND". This introduces a confusion that is amplified by the CDC 344 use of more labels, and different formulation and different combinations of the criteria used to 345 attribute a label to a new variant. According to WHO a label is supposedly assigned to a variant 346 through a comparative assessment with the previous ones. been labeled VOC while it has never been one. Therefore, to solve the dilemma between the 361 necessity of rapidly labeling new variant and the lack of scientific evidences, a good way is to 362 analyze thoroughly the genetic variations observed to generate rapidly the best data on the potential 363 attributes of the new viral variant. To achieve this analysis, the computational prediction of variant 364 effect on protein stability, function and interaction is a very useful way to determine the variant 365 "importance". Several methods can be used based on the availability or not of 3D structure of the 366 protein.

In this study, we show that computational prediction and in silico comparative studies 367

between new variants and older more characterized ones, can provide good insights into the impact 368 of the mutations and thus the potential behavior of the emergent variants. Indeed, the observation 369 that most of the mutations in SARS-CoV-2 VOCs map to the solvent exposed regions along with 370

the comparison of antigenicity predictions, represent a good basis to make a fair assumption on a 371 potential immune escape and/or a likely reduction of antibodies neutralization and to anticipate an 372 evaluation of vaccine effectiveness. In addition, the comparative analysis of the S protein 3D 373 structure between the five SARS-CoV-2 VOCs showed an identical overall folding as 374 demonstrated by the RMSD values and Tm-scores of each model. Meanwhile the comparison of 375 contact residues maps gave a fine tuning of the structural divergence which suggest potential 376 functional differences that need to be further analyzed. Therefore, it is recommended to integrate the data on multiple mutations with computing of various 408 viral structural features to make the best predictions and attribute the right label to a given variant.

In conclusion, the system of SARS-CoV-2 labeling developed by WHO and amended by the CDC 411 has some major flaws. Relying on the integrated biophysical and structural data generated from 533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  Tables   560  561  562   Table 1 599  600  601  602  603  604  605  606  607  608  609  610  611  612  613  614  615  616  617  618  619  620  621  622  623  624  625  626  627  628  629  630  631  632  633  634  635 Contact map % TM-align 

Figure 1: Matrix showing the commonalities and discrepancies of the criteria used by WHO 658 and the CDC to label SARS CoV-2 variants. The colors green and yellow indicate the criteria 659 used by WHO and the CDC respectively. The red indicates the criteria used by both agencies for 660 a same label

Mapping of the nonsynonymous mutations' characteristics of the SARS-CoV-2 five 664 variants. A typical genomic organization of SARS-CoV-2 contains the following: 5' end UTR

The accessory genes such as (3a, 3b, 667 6, 7a, 7b, 8, 10 &14) are distributed among the structural genes. The 3' end UTR and follows the 668 poly (A) tail. The green, yellow, blue purple and red show respectively the synonymous mutations 669 characteristic of variant the Alpha (α) variant (B.1.1.7), Beta (β) variant (B.1.351), Omicron (ο) 670 variant (B.1.1.529), Gamma (γ) Variant (P.1) and Delta (δ) variant (B.1.617.2). The (-) represents 671 the deletion, (*) represents the stop codon

Representation of the surface models of SARS CoV-2 variant S spike protein 675 (monomer)

S1 subunit (Cyan), S2 subunit (Green), Furin Cleavage Site (Yellow), Fusion 677 peptides FP1 and FP2 (Black)

The percentage of solvent exposed residues in the S protein of the five SARS-680 CoV-2 VOCs

This figure represents the 3D models generated for the and variants, their 683 structural analysis and the quality assessment by superimposition with the chain B of the 684 crystalized model PBD 6VXX (A) Superimposition RMSD values (B) Calculated common contact 685 percentages and Tm-scores